Mar 29, 2018
The Food and Drug Administration (FDA) has approved two new antiretroviral (ARV) combination tablets, the single-tablet regimen Symfi Lo (efavirenz/lamivudine/tenofovir disoproxil fumarate) and the two-drug tablet Cimduo (tenofovir disoproxil fumarate/lamivudine). Mylan has indicated that the company intends to offer the tablets at a significant discount compared with the price of similar ARV treatments.